ZNF300P1 and ovarian carcinoma: Given that ZNF300 is up-regulated in cancer, and promotes inflammation and metastasis, the repression of ZNF300P1 associated with methylation in ovarian cancer make it unlikely to be functioning as an miRNA decoy.